TELA Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference

MALVERN, Pa., July 29, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will participate in the Canaccord Genuity 46(th) Annual Growth Conference.

TELA’s management is scheduled to present at the Canaccord Genuity 46(th) Annual Growth Conference at 8:30 am ET on August 12(th), 2026. Interested parties can access the live and archived webcast at ir.telabio.com.